Tengion is a clinical-stage biotechnology company and a leader in regenerative medicine. Tengion’s pioneering Organ Regeneration Platform enables the company to create proprietary product candidates that are meant to harness the body’s intrinsic regenerative pathways to produce an array of native-like organs and tissues. The company’s product candidates are aimed at eliminating the necessity of procuring donor organs, administering anti-rejection medications, or utilizing body tissues for purposes they are ill-suited for. For more information, visit the company’s Web site at www.tengion.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: